5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer

NCT00359606 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: 5-Fluoro-2-Deoxycytidine (FdCyd)
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Tetrahydrouridine (THU)

Sponsor

City of Hope Medical Center

Collaborators

[object Object]